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Mother-to-child transmission of HIV is the leading cause of pediatric AIDS; 
however, mechanisms by which HIV compromises pregnancy are not understood.  
CD4+CD25+ T-regulatory (Treg) cells play a role in pregnancy maintenance.  RNA from 
early and late gestation placentas and fetuses from FIV-infected and control cats were 
probed for expression of FIV gag and Treg markers CD25, FOXP3, and CTLA4, using 
real time reverse-transcriptase (RT)-PCR.  High rates of vertical transmission and 
reproductive failure were detected in early and late pregnancy.  In control animals, both 
FOXP3 and CTLA4 expression decreased with gestational stage, indicating a natural 
decline in Tregs.  Expression of FOXP3 and CTLA4 was decreased at early gestation in 
FIV-infected queens and a trend toward decreased expression of CD25, FOXP3, and 
CTLA4 in placentas from FIV-infected queens producing non-viable pregnancies was 
observed as well.  Our results suggest that FIV infection may alter placental Treg 
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REVIEW OF PERTINENT LITERATURE  
 
The AIDS epidemic remains a global scourge despite effective antiretroviral 
therapy.  In the United States alone, more than 56,000 new HIV infections occur each 
year (NIAID, 2008).  In 2007, there were an estimated 33 million people living with HIV 
globally, and more than 420,000 children were newly infected with HIV.  Pediatric 
infections represented 16% of new HIV infections; more than 1,100 new HIV infections 
of children occur daily (UNAIDS, 2008).  Mother-to-child transmission (MTCT) of HIV 
is the leading cause of pediatric AIDS cases worldwide, accounting for more than 90% of 
pediatric infections (CDC, 2008).  As pre- and perinatal services to prevent mother-to-
child transmission have expanded, the annual number of new HIV infections among 
children, worldwide, has declined since 2002.  With the use of antiretroviral therapy by 
pregnant women and cesarean delivery of their babies, MTCT can be reduced to less than 
1% (NIAID, 2008).  However, without antiretroviral therapy, one-fourth to one-third of 
HIV-infected women will transmit the virus to their babies.    
HIV infection may contribute to compromised pregnancy and reproductive 
failure.  Adverse pregnancy outcome, including increased levels of miscarriage, stillbirth, 
pre-term delivery, and low birth weight was significantly increased in HIV-infected 
women from the U.S., Europe, Asia, and Africa (Kumar et al., 1995; D'Ubaldo et al., 
1998; Goldstein, 2000; Anderson, 2001; Rollins et al., 2007).  Langston et al (1995) 
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evaluated miscarriage rates in a group of HIV-infected women from the United States 
and reported that spontaneous fetal loss occurred in 14/124 pregnancies ranging from 8 to 
32 weeks gestation.  HIV was detected in 7/12 of the aborted fetal tissues, four of which 
were 18 weeks gestation and younger, and three of which were older than 32 weeks.  On 
the other hand, other studies revealed no differences in reproductive outcome between 
HIV seropositive and negative women (Massad et al., 2004). 
 
FIV as a model for HIV 
 
FIV and HIV are both T lymphotropic lentiviruses that belong to the family 
Retroviridae.  Like HIV, FIV uses CXCR4, a chemokine receptor, as a co-receptor, but 
the two viruses differ in their primary receptor.  Whereas HIV uses CD4 as its primary 
receptor, FIV uses CD134 (OX40), a T cell activation marker (Shimojima et al., 2004).  
These receptors are used for viral adherence and penetration into the host cell by fusion.  
FIV binds to the receptors via its 95 Kd surface glycoprotein (gp95) (Bendinelli et al., 
1995).  Gp95 binds to CD134, causing a conformational change that allows gp95 to bind 
to CXCR4.  A hydrophobic fusion peptide of the 40 Kd transmembrane glycoprotein 
(gp40) is inserted into the membrane of the cell, consequently causing the fusion of the 
viral and cellular membranes.  The viral capsid is internalized into the cell while the viral 
envelope remains associated with the cellular membrane.    
 FIV was first isolated from a group of domestic cats in Petaluma, California in 
1986 (Pedersen et al., 1987), and its similarity to HIV was quickly recognized.  Feline 
disease caused by FIV infection is similar to that produced in HIV-infected humans in 
both clinical outcome and stages of disease progression (Diehl et al., 1995).  Importantly, 
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this is the only animal model system for HIV wherein immunodeficiency results from 
infection of the natural host.  Thus, the FIV-infected cat is a suitable small animal model 
for HIV-induced immunodeficiency in humans.    
There are three stages of feline disease progression: acute, latent, and AIDS-like 
stage.  The acute stage, occurring four to six weeks after infection, is characterized by an 
initial burst of virus replication and a high circulating virus load (Diehl et al., 1995).  This 
stage is accompanied by non-specific signs such as fever, depression, swollen lymph 
nodes, gingivitis, and susceptibility to skin or intestinal infections.  Further progression of 
the disease leads to the latent or subclinical stage, which can last for many years.  In this 
stage, there are no signs of disease but the virus slowly weakens the host immune system, 
as CD4+ T cells are progressively depleted (Bendinelli et al., 1995).  The final or AIDS-
like stage occurs as a result of immunosuppression.  Depletion of CD4+ T cells results in 
inversion of the CD4: CD8 T cell ratio (Garg et al., 2004).  During this final phase, the 
host is more prone to chronic infections of the oral cavity and upper respiratory tract, 
opportunistic diseases that cause serious illness, and cancer.  The ultimate outcome is 
usually death. 
Shimojima et al (2004) reported that CD4+ T lymphocyte depletion is due to 
syncytium formation that occurs when an FIV-infected T cell expressing FIV envelope 
(Env) glycoprotein on its surface comes in contact with an adjacent cell expressing 
CD134 and CXCR4.  Garg et al (2004) reported that Env binding to CD134 can induce 
apoptosis in non-infected cells and that cell death is also related to an increase in the 
expression of FIV co-receptor, CXCR4.   
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The FIV-infected cat also provides an excellent model for MTCT.  Like HIV, FIV 
can be transplacentally transmitted (O'Neil et al., 1996).  Transplacental transmission of 
FIV occurs readily during experimental infection with some FIV isolates, producing 
frequent reproductive failure (Boudreaux et al., 2009; O'Neil et al., 1996; Rogers and 
Hoover, 1998; Weaver et al., 2005).  High rates of MTCT were reported using FIV 
isolates from clades A, B, and C (O'Neil et al., 1996; Rogers and Hoover, 1998).  Rogers 
and Hoover (1998) reported that in utero infection rate increased from 0% at 3 weeks 
gestation to 60% at nine weeks in FIV-B-2542-infected queens.  We detected provirus in 
21/22 offspring (95%) delivered by cesarean section from infected queens during week 8 
of gestation (Weaver et al., 2005) and viral RNA in 12/14 fetuses (86%) delivered during 
week 3-4 gestation (Boudreaux et al., 2009) using the same isolate.   
 
Placental Immunity and Pregnancy Maintenance 
 
Pregnancy is a natural phenomenon requiring the maternal immune system to 
tolerate the presence of the semi-allogeneic fetus while maintaining a normal immune 
response to protect the mother from infection.  The placental immune response must be 
precisely balanced to accomplish this feat.  Placental immunomodulation requires the 
production of an assortment of cytokines which aid in the maintenance of pregnancy 
(Denison et al., 1998).  T-helper 2 (Th2) cytokines are favored at the maternal-fetal 
interface.  For example, IL-10 is a potent immunomodulatory cytokine whose expression 
is associated with a successful pregnancy outcome (Denison et al., 1998).  This cytokine 
is among the Th2 cytokines favored at the maternal-fetal interface.  Th2 cytokines 
promote the development of a humoral immune response and suppress cell-mediated 
immunity induced by Th1 cytokines, which could lead to fetal death and abortion.  
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Dysregulation of cytokine expression can adversely affect pregnancy outcome.  For 
instance, TNF-α is commonly produced during late pregnancy, possibly stimulating 
uterine contractions to induce labor.  If produced during early pregnancy, this cytokine 
enhances the chances of spontaneous abortion by inducing natural killer cell activity.   
However, cytokine expression that did not fit the typical Th1/Th2 dichotomy was found 
at the maternal-fetal interface of mice.  For example, inflammatory (IL-12, IL-15) and 
anti-inflammatory (IL-11, IL-13) cytokines were identified at the maternal-fetal interface 
in mice at various stages of pregnancy (Zourbas et al., 2001).  Bates et al (2002) reported 
that in-vitro stimulated PBMCs from pregnant women produced more IL-10 and 
significantly less TNF-α and IFN-γ than non-pregnant women.  This group also reported 
that IL-10 was more markedly increased and TNF-α and IFN-γ expression was further 
reduced in women with recurrent pregnancy loss.  
Cytokine production in the human placenta is affected by HIV infection.  
Increased expression of pro-inflammatory cytokines, such as IL-1β, IFN-γ, and TNF-α is 
associated with primary immune response to HIV infection, whereas levels of IL-2 and 
IL-4 are absent or barely detectable in the peripheral blood (Graziosi et al., 1996).  The 
expression of IL-1β, IL-6, and TNF-α was elevated in HIV-infected placental 
trophoblasts compared to control placentas (Lee et al., 1997).  Furthermore, HIV 
infection often produces increased expression of IFN-γ (Graziosi et al., 1996) and 
decreased IL-2 production which contributes to progression to AIDS (Legrand et al., 






CD4+CD25+ T Regulatory Cells 
 
CD4+CD25+ T regulatory cells (Tregs) are immunosuppressive, thereby 
maintaining immune system homeostasis and tolerance to self antigens.  They play a 
major role in the suppression of graft rejection and innate mucosal immunity.  Tregs that 
are thymus derived and directed towards self antigens are known as naturally occurring 
Tregs, while Tregs derived from mature T cells in peripheral organs after antigenic 
stimulation are called adaptive Tregs.   
Tregs are characterized by the expression CD25, forkhead box P3 transcription 
factor (FOXP3), and cytotoxic T lymphocyte antigen 4 (CTLA4).  CD25 represents the 
alpha chain of the interleukin 2 receptor (IL-2Rα).  It is upregulated on naïve T cells after 
antigenic stimulation and differentiation into adaptive Tregs.  However, CD25 expression 
is not restricted to Tregs.  Activated T cells, such as CD8+ T cells (Woo et al., 2001), and 
B cells express CD25 after antigenic stimulation (Lowenthal et al., 1985).  FOXP3 is a 
transcriptional activator that plays a major role in the regulation of Treg function and 
differentiation (Zheng and Rudensky, 2007).  Sustained expression of FOXP3 is 
necessary to program cells for Treg function (Gavin et al., 2007).  Like CD25, it is 
expressed by naturally occurring Tregs and can be upregulated upon activation and 
differentiation of CD4+CD25- T cells to adaptive Tregs.  FOXP3 was also detected in 
small amounts in CD4+CD25-, CD8+, and CD21+ lymphocytes in the cat (Lankford et 
al., 2008), but it was expressed much more abundantly in CD4+CD25+ T cells.  CTLA4 
is also an activation marker expressed by adaptive Tregs and naturally occurring Tregs.  
B7 receptors on antigen presenting cells initially engage the CD28 receptor on CD4+ T 
cells, transducing a signal that upregulates the production of IL-2.  CTLA4 is induced 
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approximately 24-48 hours after activation of the T cell (Krummel and Allison, 1996).  It 
outcompetes CD28 for B7 binding (Tompkins and Tompkins, 2008) and acts as a 
negative regulator of T cell activation by preventing cell proliferation, cell cycle 
progression, and  IL-2 production (Krummel and Allison, 1996).   
 CD4+CD25+ T cells comprise 5-10% of the total T cell population in the blood of 
normal rodents and humans (Vahlenkamp et al., 2004).  Their means of 
immunosuppression is either through the release of cytokines, such as IL-4 and IL-10 
(Thornton and Shevach, 1998) or through cell-contact dependent transcriptional down-
regulation of IL-2 (Quack et al., 2001; Shevach, 2002; Thornton and Shevach, 2000).  
CD4+CD25+ Tregs suppress CD4+ and CD8+ T cell responses, e.g. proliferation and 
cytokine production, to HIV antigens in infected individuals (Kinter et al., 2007a; Kinter 
et al., 2007b).  These mechanisms of suppression are cell-contact dependent and cytokine 
independent; and they support the idea that CD4+CD25+ Tregs specific for HIV antigens 
may contribute to the general immunosuppression during HIV infection (Vahlenkamp et 
al., 2005).  Another means by which Tregs suppress immune activation is via modulation 
of tryptophan catabolism (Fallarino et al., 2003).  Indoleamine 2,3-dioxygenase (IDO), a 
tryptophan-catabolizing enzyme produced by antigen presenting cells, suppresses T cell 
proliferation by the depletion of tryptophan (Mellor et al., 2001; Munn et al., 1998).  IDO 
activation is dependent upon IFN-γ expression by dendritic cells and CTLA4 expression 








Tregs and Pregnancy Maintenance 
 
Tregs play a crucial role in pregnancy maintenance.  T cells with similar 
phenotype and function as adult Tregs were detected in umbilical venous blood from 
healthy newborn infants (Ng et al., 2001).  Human fetal T cells are highly responsive to 
antigenic stimulation in the absence of CD4+CD25+ Tregs (Michaelsson et al., 2006).   
Mold et al. (2008) reported that depletion of fetal Tregs resulted in a significant increase 
in proliferation of fetal T cells against maternal APCs.  The increase in fetal T cell 
proliferation provided evidence that fetal T cells are not deficient at responding to 
maternal alloantigen, but rather, their function is actively suppressed by fetal Tregs.  
While fetal Tregs allow fetal tolerance of maternal alloantigens (Mold et al., 2008), 
placental Tregs allow maternal tolerance of the semi-allogeneic fetus (Michaelsson et al., 
2006; Zenclussen et al., 2005) in both the mouse model and in humans.  In the human 
decidua, CD4+CD25+ T cells comprise approximately 10% of CD4+ T cells during early 
pregnancy (Chao et al., 2002) and 14% of CD4+ T cells at term (Heikkinen et al., 2004).  
Successful pregnancy is generally associated with higher levels of activated Tregs in both 
the periphery and the decidua (Sasaki et al., 2004; Somerset et al., 2004; Zhu et al., 
2005).  Others report expansion of Tregs in the periphery from early to mid-gestation, 
followed by a decrease to pre-pregnancy levels at term (Somerset et al., 2004).  A 
concomitant decrease in CD4+CD25(high) and increase in CD4+CD25(low) T cells was 








Feline Tregs and FIV Infection 
 
Feline Tregs are characterized most definitively by co-expression of CD4, CD25, 
and FOXP3.  These cells comprise 5 to 10% of the total CD4+ T cells in the blood and 20 
to 30% of lymph node CD4+ T cells and express many phenotypic and functional 
characteristics of their human and murine counterparts.  They are anergic, do not produce 
IL-2, are responsive to LPS, and are capable of suppressing CD4+CD25- T cells 
(Vahlenkamp et al., 2004).   
CD4+CD25+ T cells support productive replication of FIV.  While both 
CD4+CD25+ and CD4+CD25- T cells may be latently infected with FIV, the state of 
activation of these cells dictates whether or not productive infection occurs.  
CD4+CD25+ T cells stimulated with low levels of IL-2 support FIV replication.  
However, stimulation of latently-infected CD4+CD25- T cells with potent mitogens such 
as concanavalin A or high levels of IL-2 is required to promote productive infection, 
correlating with upregulation of CD25 expression in these cells (Joshi et al., 2004).  This 
pattern of replication parallels that of HIV, which also infects both CD4+CD25+ and 
CD4+CD25- T cells, but in the absence of additional activation, only the CD25+ T cells 
produce viral protein.  Reasons for preferential FIV replication in these regulatory T cells 
were revealed by Joshi et al (2005).  This group found that CD4+CD25+ T cells 
expressed higher levels of CXCR4 and CD134 than CD4+CD25- T cells, and FIV entry 
showed a positive correlation with levels of CXCR4 expression.  Moreover, 
CD4+CD25+ T cells constitutively expressed transcriptional activators which bind the 
FIV long terminal repeat (LTR) and enhance viral replication.  CD4+CD25- T cells 
constitutively expressed very low levels of the transcriptional activators, all of which 
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were up-regulated by concanavalin A stimulation.  Expression of co-stimulatory 
molecules B7.1, B7.2, and CTLA4 on blood or lymph node Tregs is upregulated in FIV-
infected animals (Vahlenkamp et al., 2004).   
Cell death is related to an increase in the expression of CXCR4, and the binding 
of FIV envelope glycoprotein to CD134 can induce apoptosis in non-infected cells (Garg 
et al., 2004).  These findings correlate with the depletion of CD4+ T cells after infection 
and the inversion of the CD4:CD8 ratio.  Moreover, they also relate to Treg susceptibility 
to FIV infection, since these cells express the FIV primary and coreceptors (Shimojima et 
al., 2004).  Joshi et al (2005) reported that CD4+CD25+ T cells express more CXCR4 
and CD134 than CD4+CD25- T cells, and therefore, CD4+CD25+ T cells are more 
susceptible to FIV binding and entry.  Likewise, Human CD4+CD25+ T cells support the 
replication of HIV more efficiently than CD4+CD25- T cells (Chou et al., 1997).  It has 
been proposed that Tregs are depleted in HIV infection, and that this depletion, along 
with viremia, stimulates CD4+ and CD8+ T cell activation (Eggena et al., 2005).  This 
immune activation may lead to increased apoptosis of T-helper cells or increased viral 
replication and infection (Eggena et al., 2005).  Consequently, this type of activation 
silences the host immune system and gives way to the progression of the disease. 
 
Significance and Purpose 
 
 Pediatric AIDS remains an important component of the AIDS pandemic, and 
MTCT accounts for more than 90% of pediatric infections (CDC, 2008).  Moreover, 
transplacentally-acquired HIV infections frequently result in poor pregnancy outcome, 
including increased rates of miscarriage and low birth weight babies (Anderson, 2001; 
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D'Ubaldo et al., 1998; Goldstein, 2000; Kumar et al., 1995; Rollins et al., 2007).  Yet, 
despite more than two decades of research, mechanisms by which HIV compromise 
pregnancy remain poorly understood.  Using the FIV-infected cat model, we 
demonstrated very high rates MTCT and reproductive failure at both early and late 
pregnancy.  Moreover, our data indicate that placental inflammation may be associated 
with poor pregnancy outcome (Weaver et al., 2005).  Given the importance of placental 
Tregs in pregnancy maintenance reported for both human and murine systems, we 
believe feline placental Tregs may be implicated in the cat system as well.  Therefore, we 
hypothesized that FIV infection in pregnant cats alters placental Treg population 
dynamics in the placenta, thereby causing aberrant placental inflammation that 
potentiates vertical transmission and adversely affects reproductive outcome.  Our aim 
was to use the cat model to provide an early glimpse into possible mechanisms by which 
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EXPRESSION OF REGULATORY T CELL (TREG) ACTIVATION MARKERS IN 
PLACENTAL TISSUES FROM EARLY AND LATE PREGNANCY IN THE FELINE 
IMMUNODEFICIENCY VIRUS (FIV)-INFECTED CAT 
 
Abstract 
Regulatory T cells (Tregs) support pregnancy maintenance by suppressing 
placental inflammation, while diminished placental Treg function may accompany 
reproductive failure.  Experimental FIV infection results in frequent vertical transmission 
and increased pregnancy failure in the cat.  The mechanism of reproductive compromise 
is unknown.  We hypothesized that FIV infection alters placental Treg population 
dynamics and function, potentiating vertical transmission and reproductive failure.  RNA 
collected from early and late gestation placentas and fetuses from FIV-infected and 
control cats was probed for expression of FIV gag and the Treg markers CD25, FOXP3, 
and CTLA4, using real time reverse-transcriptase (RT)-PCR.  A high rate of placental 
and fetal infection and frequent reproductive failure was detected at early and late 
pregnancy.  Expression of FOXP3 and CTLA4 was higher in early gestation placentas 
from control cats.  FIV infection significantly reduced expression of FOXP3 at early, but 
not late pregnancy.  At late pregnancy, CTLA4 was expressed to higher levels in infected 
placentas.  No significant changes in CD25 expression occurred between FIV-infected 
and control placentas at early or late pregnancy.  There was no significant difference in 
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the Treg marker expression between viable and non-viable pregnancies in infected cats, 
although a trend toward decreased expression of CD25 and FOXP3 accompanied non-
viable pregnancy.  The detection of Treg markers in feline placental tissues provides the 
first evidence of feline placental Tregs and suggests that such cells diminish as pregnancy 
progresses.  These cells may be depleted or rendered less functional by viral infection, 
but their role in pregnancy maintenance is unclear.  
 
Introduction 
Mother-to-child transmission of HIV is the leading cause of pediatric AIDS 
worldwide (UNAIDS, 2008).  Adverse pregnancy outcome, including increased levels of 
miscarriage, stillbirth, pre-term delivery, and low birth weight was significantly increased 
in HIV-infected women from the U.S., Europe, Asia, and Africa (Kumar et al., 1995; 
D'Ubaldo et al., 1998; Goldstein, 2000; Anderson, 2001; Rollins et al., 2007), yet 
mechanisms by which HIV compromises pregnancy are not understood.   
FIV naturally produces a syndrome culminating in feline AIDS and terminal 
susceptibility to opportunistic infections and cancer, similar to progression to AIDS in 
HIV-infected humans.  Transplacental transmission of FIV occurs readily during 
experimental infection with some FIV isolates, producing frequent reproductive failure 
(O'Neil et al., 1996; Rogers and Hoover, 1998; Weaver et al., 2005; Boudreaux et al., 
2009).  Thus, the FIV-infected cat provides a useful small animal model for HIV 
pathogenesis and MTCT.   
Tregs, characterized by the expression of the alpha chain of the interleukin 2 
receptor (IL-2Rα or CD25), forkhead transcription factor (FOXP3) and cytotoxic T 
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lymphocyte antigen 4 (CTLA4), are immunosuppressive, maintaining immune system 
homeostasis and tolerance to self antigens.  They play a major role in the suppression of 
graft rejection and innate mucosal immunity (Maloy et al., 2003).  These cells also play a 
crucial role in pregnancy maintenance.  In both the mouse model and in humans, 
placental Tregs allow maternal tolerance of the semi-allogeneic fetus (Zenclussen et al., 
2005; Michaelsson et al., 2006), while fetal Tregs allow fetal tolerance of maternal 
alloantigens (Mold et al., 2008).  In the human decidua, Tregs comprise approximately 
10% of CD4+ T cells during early pregnancy (Chao et al., 2002) and 14% of CD4+ T 
cells at term (Heikkinen et al., 2004).  A successful pregnancy is associated with higher 
levels of activated Tregs in both the periphery and the decidua (Sasaki et al., 2004; 
Somerset et al., 2004; Zhu et al., 2005).  During normal human pregnancy, 
CD4+CD25
high
CTLA4 Treg cells increase, but decrease to pre-pregnancy levels if 
pregnancy fails (Sasaki et al., 2004).   
Feline Tregs are characterized most definitively by co-expression of CD4, CD25, 
and FOXP3 (Lankford et al., 2008).  Like human and murine Tregs, feline Tregs 
comprise 5-10% of the total CD4+ T cells in the blood and 20-30% of lymph node CD4+ 
T cells and express many of the same phenotypic and functional characteristics 
(Vahlenkamp et al., 2004).  These cells support productive replication of FIV.  Joshi et al 
(2005) found that CD4+CD25+ T cells express higher levels of CXCR4 and CD134 than 
CD4+CD25- T cells, and FIV entry positively correlates with levels of CXCR4 
expression.  In addition, CD4+CD25+ T cells constitutively express transcriptional 
activators which bind the FIV long terminal repeat (LTR), enhancing viral replication.  
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Expression of co-stimulatory molecules B7.1, B7.2, and CTLA4 on blood or lymph node 
Tregs is upregulated in FIV-infected animals (Vahlenkamp et al., 2004).   
We previously reported very high rates of MTCT and frequent reproductive 
failure in FIV-infected queens at both early and late pregnancy (Weaver et al., 2005; 
Boudreaux et al., 2009).  Increased expression of two inflammatory cytokines 
accompanied pregnancy failure in the FIV-infected cat (Weaver et al., 2005).  Moreover, 
successful pregnancy was accompanied by higher levels of CD134 and CXCR4 
expression (Scott et al., 2008), suggesting that cells bearing these markers, such as Tregs, 
may be important to pregnancy maintenance.  The data indicate that FIV infection results 
in enhanced inflammation in the feline placenta.  We hypothesize that FIV infection in 
pregnant cats alters placental Treg population dynamics in the placenta, thereby causing 
aberrant placental inflammation that potentiates vertical transmission and possibly 
reproductive failure.  Both placentas and fetal/kitten tissues were evaluated for viral 
infection.  Expression of the Treg markers CD25, FOXP3 and CTLA4 was quantified in 
random sections of placental tissues obtained from FIV-infected and control queens 
producing viable and non-viable offspring at early and late pregnancy.  Both FOXP3 and 
CTLA4 expression decreased with gestational stage in control animals, indicating a 
possible natural decline in Tregs from early to late pregnancy.  We found a very high rate 
of viral infection in both placentas and offspring, accompanied by significant or near 
significant decreases in FOXP3 and CTLA4 expression at early gestation in FIV-infected 
queens.  Although not significant, there was a trend toward decreased expression of 
CD25, FOXP3, and CTLA4 in placentas from non-viable pregnancies.  Collectively, the 
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data suggest that FIV infection may alter placental Treg function, thereby adversely 
affecting pregnancy outcome.  
 
Materials and Methods 
 
 
Animals and Virus 
 
Two groups of twenty, reproductively mature, specific pathogen-free animals 
(SPF), obtained from a commercial cattery, were used to evaluate early and late 
pregnancy.  Ten queens from each study group were inoculated intravenously with a 
feline plasma pool containing approximately 1.3 x 10
4
 copies/ml of FIV-B-2542, 
originally provided by Dr. Edward A. Hoover (Rogers and Hoover, 1998).  The other ten 
queens in each group were used as controls.  All procedures involving the cats were 
performed with approval of the Mississippi State University Institutional Animal Care 
and Use Committee. 
 
Tissue Collection 
Following confirmation of FIV infection using PCR and serology, the cats were 
allowed to breed naturally with SPF males.  Pregnancies were confirmed by 
ultrasonography and terminated at week 3-4 (early) or week 8 (late).  The time of FIV 
inoculation to delivery ranged from approximately 9.5 to 13.5 months (mean 11.14 
months) for the early gestation study and 4.7 to 14.1 months (mean 9.5 months) for the 
late gestation study.  Kittens from both FIV-infected and control queens were delivered 
by cesarean section.  The placentas were collected from the gestational sacs, labeled by 
the number of the queen, and given an alphabetical designation.  Fetuses and placentas 
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were collected, snap frozen in liquid nitrogen or formalin fixed, then stored at -80°C 
(Weaver et al., 2005).  
 
RNA Isolation  
RNA was isolated from early and late term placental tissues using TRIzol Reagent 
(Invitrogen, Corp. Carlsbad, CA).  According to the manufacturer’s instructions, the 
tissues was submerged in 1 ml TRIzol Reagent and homogenized.  Homogenates were 
supplemented with 0.2 ml chloroform and allowed to sit for 5 min at an ambient 
temperature (20–25°C).  Samples were covered and vigorously shaken for 15 s.  The 
resulting mixture was allowed to sit at room temperature for 15 min.  Samples were then 
centrifuged at 12,000 x g for 15 min.  Next, the colorless upper aqueous phase containing 
RNA was transferred to a fresh tube.  RNA was precipitated from the aqueous phase with 
the addition of 0.5 ml isopropanol and incubated at room temperature for 10 min.  The 
RNA precipitate was then pelleted by centrifugation at 12,000 x g for 8 min, and the 
supernatant was removed.  The RNA pellet was washed by vortexing with 1 ml of 75% 
ethanol and centrifuged at 12,000 x g for 5 min.  The ethanol wash was removed, and the 
RNA pellet was air-dried for 5 min.  After drying, the RNA pellet was dissolved in 100 
µl of RNase-free water and incubated for 15 min in a 55–60 °C water bath.  RNA 
concentrations were determined using a NanoDrop 1000 (Thermo Scientific, Waltham, 




Primer and Probe sets  
 Primers for CTLA4 and CD25 (IL-2Rα) were designed using cytokine mRNA 
sequences for the cat and human obtained from the National Center for Biotechnology 
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Information (NCBI) and aligned using the European Molecular Biology Laboratory-
European Bioinformatics Institute (EMBL-EBI) Clustal W alignment tool.  The human 
mRNA was BLAST searched against the human genome to locate the exon/intron 
boundaries and used to find the homologous boundaries in the feline sequences.  Real-
time PCR (Taqman) primer design (Genscript) was used to design primer/probe sets 
targeting CTLA-4 and CD25.  Each target sequence was entered in the software with 
semicolons to indicate the boundaries.  The primer/probe sets were compared and the best 
set was chosen according to its amplicon size, length, and GC%.  The target probes were 
5’ labeled with the reporter dye FAM (6-carboxyfluorescein) and 3’ labeled with the 
quencher dye TAMRA (6-carboxytetramethylrhodamine).  β-actin was 5’ labeled with 
the reporter dye HEX (hexachloro-6-carboxyfluorescein) and 3’ labeled with the 
quencher dye TAMRA.  Primer/probe sets (Table 2.1) for FOXP3 (Lankford et al., 2008), 
β-actin (Scott et al., 2008), FIV gag (Weaver et al., 2005), CTLA4, and CD25 were 
obtained commercially (MWG-BIOTECH, Inc., High Point, NC).
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Table 2.1   Sequences of Primers and Probes used in Real Time RT-PCR 
 






































 Real Time Reverse-Transcriptase (RT)-PCR 
Gene expression was determined using TaqMan real time RT-PCR targeting 
FOXP3, CTLA4, CD25, FIV gag, and the housekeeping gene β-actin.  Each reaction 
contained 12.5 µl of the commercial reaction mix, 0.5 µl of ThermoscriptTM 
Plus/Platinum1 Taq Mix (Invitrogen), 1 µl of forward and reverse β-actin primers (7.5 
pmol/µl), 1 µl of forward and reverse target primers (10 pmol/µl), 1 µl of the respective 
probe (100 fmol/µl), and 30-50 ng/µl RNA.  Real time RT-PCR was run on an iCycler 
(BioRad Laboratories, Valencia, CA) as follows: 50°C, 30 min; 95°C, 5 min; 45 x (95°C, 
15 s; 60°C, 1 min).  For every placental RNA sample, parallel reactions were run in 
duplicate.  Serially-diluted RNA from control cats was used to generate a standard curve.  
The standard curves were used to normalize for differences in PCR efficiency.  
Differences in the amount of template RNA in each reaction were corrected by the cycle 
threshold (Ct) value for β-actin.  For assurance that the integrity of RNA isolated from 
frozen early and late gestation tissues was equivalent, mean Ct values for β-actin, 
obtained by amplifying multiple replicas from 35 early placental samples and 31 late 
placental samples, were compared.  β-actin mean Ct values for the two sets of tissues 
differed by 0.25 Ct. 
 
Statistical Analysis  
Statistical comparisons of mean Ct values between groups were done using 











The effect of FIV infection on pregnancy outcome at early and late gestation was 
reported previously (Weaver et al., 2005; Boudreaux et al., 2009), and the data are 
summarized in Table 2.2.  Briefly, at late gestation, fetal non-viability was 60% (15/25 
fetuses) in FIV-infected queens and 3.2% (1/31) in control queens; differences in non-
viable offspring produced between the two groups were significant (p=0.04).  Two 
infected queens did not conceive after repeated attempts at breeding.  At early gestation, 
fetal non-viability of 22.2% (6/27) in infected queens and 4.7% (2/43) in control animals.  
The difference in the number of viable fetuses between the infected and control groups, 
nearly 50% fewer in infected cats, was significant (p=0.02).  Although three times higher 
in the infected group, fetal non-viability failed to reach the traditional level of 
significance (p>0.05).  Two infected queens did not conceive as a result of pyometra or 
ovarian cysts; another developed right horn pyometra but developed three fetuses in the 
left horn.  Two control cats did not become pregnant for unknown reasons.  Fetal non-
viability included resorptions and developmentally-arrested fetuses.   
 
Virus Detection in Early and Late Term Placental and Fetal Samples 
Real time RT-PCR was used to confirm the presence of viral RNA in placentas 
and fetuses collected from FIV-infected queens at early (Figure 2.1a) and late (Figure 
2.1b) pregnancy.  Limits of detection were reported (Boudreaux et al., 2009).  At early 
gestation, all placentas (17/17; 100%) and 12/14 fetuses (85.7%) tested were positive for 
viral RNA.  No accompanying fetal tissue could be collected from placentas 5111 C, 
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8035 D, and 1893 R because fetuses were resorbed (Figure 2.1a).  Fetus 8035 C (a non-
viable fetus) had the second highest level of viral RNA, based on Ct value, while no viral 
RNA was detected in littermates 8035 A (a viable fetus) and B (a non-viable fetus), 
showing variability even within a single litter.  The detection of vertical transmission of 
FIV at this early stage of gestation was a novel finding. 
Viral RNA expression was detected in most of the placental samples (10/17) 
obtained from the late term FIV-infected queens (Figure 2.1b).  Viral RNA was not 
detected in one sample from queens 9746 and 9730 and four samples from queen 13226.  
Although we were unable to detect viral RNA from all samples, provirus was detected in 
21/22 (95.5%) kittens and 14/15 (93.3%) placentas tested using standard PCR targeting a 
293 bp region of FIV gag gene followed by Southern blotting (Weaver et al., 2005).   
 
Expression of Treg Markers in Feline Placentas at Early and Late Gestation  
 Tregs can be identified by the expression of CD25, FOXP3, and CTLA4.  We 
analyzed the expression of these markers in early and late term control placental tissues 
to look for evidence of normal Treg dynamics in placental tissue as gestation progresses 
(Figure 2.2).  Evaluating placentas from only viable pregnancies, the higher level of 
expression of all three markers occurred at early pregnancy.  While the slightly lower 
level of CD25 expression at late pregnancy did not reach the level of significance 
(p=0.10), FOXP3 (p=0.006) and CTLA4 (p=0.015) expression was significantly lower at 
late pregnancy.   
The effect of FIV infection on Treg marker expression at early and late gestation 
was determined (Figure 2.3).  There was no difference in CD25 expression between 
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control and infected tissues at either early (p=0.51) or late (p=0.48) gestation (Figure 
2.3a).  At early gestation, FOXP3 expression was higher in control than infected 
placentas (p=0.004), but FOXP3 did not differ between control and infected cats at late 
pregnancy (p=0.85) (Figure 2.3b).  A trend toward higher CTLA4 expression in control 
placentas at early pregnancy did not reach the traditional level of significance (p=0.078).  
Interestingly, expression of this marker was significantly elevated in infected placentas at 
late pregnancy (p=0.009) (Figure 2.3c).   
Treg marker expression in viable versus non-viable pregnancies was compared in 
early and late term infected placentas (Figure 2.4).  No significant difference in the 
placental expression of CD25 was found between viable and non-viable pregnancies in 
infected cats in either early (p=0.34) or late term tissues (p=0.34) (Figure 2.4a).  
Likewise, the expression of FOXP3 did not differ significantly between viable and non-
viable pregnancies in infected cats at both early (p=0.39) and late pregnancy (p=0.74) 
(Figure 2.4b).  However, a trend toward decreased expression of both markers in 
placentas from non-viable pregnancies was detected at both early and late term.  Placental 
expression of CTLA4 was very similar between viable and non-viable pregnancies at 



















6108 - 4 0 0 2/0 
7284 - 4 0 0 2/0 
8059 - 6 0 0 2/0 
2779 - 7 1 0 2/1 
3550 - 4 0 0 2/0 
9276 - 5 0 1 2/1 
8291 - 4 0 0 2/0 
0373 - 7 0 0 2/0 
6062 + 3 0 0 2/0 
5111 + 2 1 0 2/1 
0866 + 5 1 0 1/1 
1126 + 4 0 0 2/0 
0326 + 1 0 0 1/0 
8035 + 1 1 2 1/3 














9522 - 3 0 0 2/0 
9581 - 2 1 0 2/0 
9746 - 6 0 0 2/0 
9801 - 6 0 0 2/0 
13634 - 3 0 0 1/0 
13668 - 2 0 0 2/0 
13671 - 4 0 0 2/0 
9674 + 1 0 0 1/0 
9730 + 2 1 2 2/0 
9745 + 2 0 4 2/4 
9806 + 3 0 0 1/0 
9809 + 1 0 0 1/0 
9810 + 1 0 0 1/0 
9813 + 1 0 2 1/0 
13226 + 0 5 0 1/5 
* RNA was tested using real time RT-PCR.  In early pregnancy, fetal non-viability was 
4.7% (2/43) in control queens and 22% (6/27) in FIV-infected queens.  The difference 
in the number of viable fetuses between the two groups was significant (p=0.02).  In 
late pregnancy, fetal non-viability was 3.2% (1/31) in control queens and 60% (15/25) 
in FIV-infected queens.  The difference in fetal non-viability at late gestation was 








Figure 2.1   Detection of FIV in Early and Late Gestation Tissues 
TaqMan real time RT-PCR analysis of FIV gag gene expression in placentas and 
corresponding fetuses from early (week 3-4) pregnancy and placentas from late (week 8) 
pregnancy in FIV-infected cats.  (a) Viral mRNA was amplified from all placental 
samples (14 of 14 samples).  FIV gag was detected in 12 of 14 in all fetal samples.  The 
asterisks indicate that no fetal tissue was collected from placenta 5111 C, 8035 D, and 
1893 R due to resorption.  (b) Viral RNA was detected in 10 of 17 placental samples 
from the late term FIV-infected queens.  Bars represent adjusted mean Ct values (50 - 

































































































































































































































































































































































































Figure 2.2   Relative Expression of Placental Treg Markers in Control Cats 
TaqMan real time RT-PCR analysis of placental expression of Treg markers CD25, 
FOXP3, and CTLA4 in early gestation control (n=18) versus late gestation control (n=13) 
samples.  Bars represent adjusted mean Ct values (50 - mean Ct), and error bars represent 
standard errors of the mean.  P values obtained from single-value ANOVA are noted.  *P 





























Figure 2.3   Relative Expression of CD25, FOXP3, and CTLA4 in Feline Placentas 
 
TaqMan real time RT-PCR analysis of placental expression of Treg markers CD25, 
FOXP3, and CTLA4 was performed using control and infected placentas at early and late 
pregnancy.  Placental samples were evaluated as follows: infected (n=17) versus control 
(n=18) at early pregnancy; and infected (n=18) versus control (n=13) at late pregnancy.  
Bars represent the adjusted mean Ct values (50 - mean Ct), bracketed by standard errors 
of the mean.  P values obtained from single-value ANOVA are noted.  *P values < 0.05 








































































Figure 2.4   Relative Expression of CD25, FOXP3, and CTLA4 in Placentas from FIV-
infected Cats 
 
Relative expression of the Treg markers in early and late term infected placentas 
producing viable versus non-viable fetuses.  The placental samples were evaluated as 
follows:  infected cats producing viable offspring (n=11) versus infected cats producing 
non-viable offspring at early pregnancy (n=6); and infected cats producing viable 
offspring (n=9) versus infected cats producing non-viable offspring at late pregnancy 
(n=9).  Bars represent adjusted mean Ct values, bracketed by standard errors of the mean.  

































































Successful pregnancy is generally associated with higher levels of activated Tregs 
in both the periphery and the decidua of humans and mice (Sasaki et al., 2004; Somerset 
et al., 2004; Zhu et al., 2005).  Expansion of Tregs in the periphery from early to mid-
gestation, followed by a decrease to pre-pregnancy levels at term was reported (Somerset 
et al., 2004).  A concomitant decrease in CD4+CD25(high) and an increase in 
CD4+CD25(low) T cells was associated with induction of labor in mice (Zhao et al., 
2007).  Expansion of the placental Treg population from early to late pregnancy was 
reported in humans (Chao et al., 2002; Heikkinen et al., 2004). 
Feline Tregs are routinely characterized by the co-expression of CD4, CD25, 
FOXP3, and CTLA4.  However, CD25 expression is not restricted to Tregs.  Activated T 
cells, such as CD8+ T cells (Woo et al., 2001), and B cells express CD25 after antigenic 
stimulation (Lowenthal et al., 1985).  FOXP3 is a transcriptional activator that plays a 
major role in the regulation of Treg function and differentiation (Zheng and Rudensky, 
2007).  It is expressed by naturally occurring Treg cells and can be upregulated upon 
activation and differentiation of CD4+CD25- T cells to adaptive Treg cells.  In the cat, 
FOXP3 was also detected in small amounts in CD4+CD25-, CD8+, and CD21+ 
lymphocytes (Lankford et al., 2008), but it was expressed much more abundantly in 
CD4+CD25+ T cells.  Sustained expression of FOXP3 is necessary to program cells for 
Treg function (Gavin et al., 2007).  CTLA4 is an activation marker expressed by adaptive 
Treg cells and naturally occurring Tregs.  CTLA4 outcompetes CD28 for B7 binding 
(Tompkins and Tompkins, 2008) and acts as a negative regulator of T cell activation by 
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preventing cell proliferation, cell cycle progression, and  IL-2 production (Krummel and 
Allison, 1996).   
 Our previous studies suggest a role for placental inflammation in reproductive 
failure in the FIV-infected cat model (Weaver et al., 2005).  Coupling this preliminary 
information with knowledge that FIV is preferentially tropic for Tregs, we suspected that 
FIV infection may alter placental Treg function, allowing placental inflammation, 
potentiating maternal-fetal transmission, and compromising pregnancy.  To lay the 
groundwork to address this question, we quantified Treg markers CD25, FOXP3, and 
CTLA4 in early and late term placental tissues from control and FIV-infected animals, 
detected placental and fetal infection, and documented reproductive outcome among our 
animals. 
MTCT occurred efficiently in chronically-infected queens by week 3-4 gestation, 
and fetal non-viability in infected queens, including resorbed and arrested fetuses, was 
22.2% compared to 4.7% in control queens (Boudreaux et al., 2009).  The detection of 
viral RNA in a non-viable fetus (8035 C) but not a viable fetus from the same litter (8035 
A), suggests that fetal death was not a direct result of fetal infection.  Such findings allow 
a role for FIV-induced placental immunopathology in pregnancy failure.  Efficient 
MTCT occurred in chronically-infected queens that delivered at late gestation (Weaver et 
al., 2005).  Fetal non-viability in infected queens, including resorbed and arrested fetuses 
was 60%, compared to 3.2% in control queens (Weaver et al., 2005).  Enhanced 
reproductive failure in FIV-infected cats was consistent with reports by others using the 
same or different FIV isolate (Rogers and Hoover, 1998). 
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We first examined placental Treg marker expression in normal, control cats 
producing viable offspring at early and late gestation to determine whether Treg 
populations change over the course of pregnancy.  The slightly higher level of expression 
of CD25 at early gestation did not significantly differ from that of late gestation.  
However, significantly higher levels of expression of FOXP3 and CTLA4 were found at 
early pregnancy.  The data suggest that cell populations expressing these Treg markers 
may be normally diminished or less activated as pregnancy progresses.  A decrease in 
number or function of Tregs may allow increased inflammation late in gestation, which is 
a normal precursor to parturition (Challis et al., 2009).   
FIV infection altered the expression of Treg markers in the placenta.  At early 
gestation, there was no difference in the expression of CD25 between control and 
infected placentas.  However, FIV infection resulted in significantly decreased expression 
of FOXP3 and decreased expression of CTLA4 that approached, but did not reach, 
significance (p=0.078).  The data suggest that at early pregnancy, Tregs may be depleted 
or rendered less functional by viral infection, resulting in the early fetal loss that we 
reported previously (Boudreaux et al., 2009).  The presence of viral RNA in early 
placenta supports this idea, although the cells harboring the virus were not specifically 
identified.  At late gestation, expression of CD25 and FOXP3 did not differ between 
control and infected placentas.  A possible explanation for this finding may be that 
natural diminution of Treg activation at late pregnancy (Figure 2) may render these cells 
less vulnerable to the impact of viral infection.  In contrast, FIV infection caused more 
CTLA4 to be expressed at this time period.  Although constitutively expressed on Tregs, 
CTLA4 is also expressed on other T cell populations 24-48 hours after activation 
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(Krummel and Allison, 1996; Tompkins and Tompkins, 2008).  Perhaps expression of 
this marker late in infection in FIV-infected cats was attributable to activation of non-
regulatory T cells, coinciding with increased inflammation.    
Finally, we wanted to determine if alterations in the putative Treg population had 
any effect on pregnancy outcome.  Although differences in expression did not reach 
traditional significance (p>0.05), the obvious trend was lower level of expression of 
CD25 and FOXP3 in placentas from non-viable pregnancies at both early and late 
pregnancy, while the mean Ct values for CTLA4 between the two groups were nearly 
identical at both time points.   
An obvious limitation of this study is that Treg populations were not directly 
enumerated nor was RNA extracted from these precise populations for gene expression 
analyses.  Rather, RNA was isolated from random placental specimens containing 
unknown quantities of Tregs.  Because even subtle changes in gene expression may be 
significant in terms of function, dilution of RNA from irrelevant cell populations may 
have masked important information.  Thus, in future studies, viral RNA will be isolated 
from microdissected, labeled Tregs for gene expression analyses.   
The value of the present study is that it provides the first evidence of feline 
placental Tregs.  It also demonstrates that FIV infection alters placental expression of 
Treg markers, possibly leading to compromised pregnancy.  The data provide an early 
glimpse into a possible mechanism for lentivirus-induced reproductive failure, clearly 
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MTCT accounts for more than 90% of pediatric HIV-infections (CDC, 2008).  
With preventative measures, such as antiretroviral therapy and cesarean delivery, MTCT 
can be reduced to less than 1% (NIAID, 2008).  Previously, we reported very high rates 
of MTCT and frequent reproductive failure in FIV-infected queens at both early and late 
pregnancy, and increased expression of two inflammatory cytokines accompanied 
pregnancy failure in the FIV-infected cat (Weaver et al., 2005).  These results suggest 
that FIV infection results in enhanced inflammation in the feline placenta.  Furthermore, 
we reported that higher levels of CD134 and CXCR4 expression accompanied successful 
pregnancy (Scott et al., 2008), suggesting that cells bearing these markers, such as Tregs, 
may be important to pregnancy maintenance.  Tregs suppress inflammation, and FIV is 
preferentially tropic for Tregs.  Thus, we suspected that FIV infection may alter placental 
Treg function, allowing placental inflammation which may potentiate maternal-fetal 
transmission and/or compromise pregnancy.   
In Chapter II of this thesis, we reported the first evidence of feline placental 
Tregs.  Our detection of Treg markers in the feline placenta establishes a noteworthy 
similarity between the feline and human reproductive systems and strengthens the FIV-
infected cat as a practical model for both HIV pathogenesis and MTCT.  We found very 
high rates of vertical transmission and reproductive failure at both early and late 
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pregnancy in infected queens.  A comparison of placentas from control queens producing 
viable fetuses from early and late gestation was performed to look for changes in Treg 
populations during the course of normal pregnancy.  Expression of FOXP3 and CTLA4 
was higher in early gestation placentas from control cats.  The data suggest that cells 
expressing those Treg markers are diminished as pregnancy progresses from early to late 
term, which may allow the natural increase in inflammation during late pregnancy.  FIV 
infection altered the Treg marker expression in the feline placenta.  Although no 
significant change in CD25 expression occurred between FIV-infected and control 
placentas at early or late pregnancy, FIV infection resulted in reduced expression of 
FOXP3 and CTLA4 at early pregnancy and increased expression of CTLA4 at late 
pregnancy.  These results suggest that, at early pregnancy, Tregs may be depleted or 
rendered less functional by viral infection.  However, at late pregnancy, the natural 
reduction of Treg activation may render these cells less vulnerable to the impact of viral 
infection.  Finally, we compared placentas from viable and non-viable pregnancies from 
FIV-infected cats to determine if alterations in the putative Treg population had any 
effect on pregnancy outcome.  We report no significant difference in Treg marker 
expression, although a trend toward decreased expression of CD25 and FOXP3 
accompanied non-viable pregnancy.  Together, our data demonstrate that FIV infection 
alters placental expression of Treg markers, coincident with adverse pregnancy outcome, 
although a causal relationship between Treg function and FIV-induced reproductive 
failure was not clearly established.  These results suggest a direction for further research 
into the mechanisms by which lentiviruses, such as HIV, compromise pregnancy, a 
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IMMUNOHISTOCHEMISTRY OF FORMALIN-FIXED PLACENTAL TISSUES 





CD4+CD25+ Tregs are immunosuppressive T cells that play a major role in the 
suppression of inflammation, graft rejection, and pregnancy maintenance.  In both the 
mouse model and in humans, placental Tregs allow maternal tolerance of the semi-
allogeneic fetus (Michaelsson et al., 2006; Zenclussen et al., 2005).  Several groups have 
reported that successful pregnancy is associated with higher levels of activated Tregs in 
both the decidua and the periphery (Sasaki et al., 2004; Somerset et al., 2004; Zhu et al., 
2005).  In the human decidua, CD4+CD25+ T cells comprise approximately 10% of 
CD4+ T cells during early pregnancy (Chao et al., 2002) and 14% of CD4+ T cells at 
term (Heikkinen et al., 2004).  Expansion of Tregs in the periphery from early to mid-
gestation followed by a decrease to pre-pregnancy levels at term was also reported 
(Somerset et al., 2004).   
Transplacentally-acquired HIV infections frequently result in poor pregnancy 
outcome, including increased rates of miscarriage, stillbirth, pre-term delivery, and low 
birth weight babies (Kumar et al., 1995; D'Ubaldo et al., 1998; Goldstein, 2000; 
Anderson, 2001; Rollins et al., 2007).  Yet, mechanisms by which HIV compromises 
pregnancy are poorly understood.  We previously reported high rates of MTCT and 
frequent reproductive failure in FIV-infected queens at both early and late pregnancy 
(Weaver et al., 2005; Boudreaux et al., 2009).  Moreover, our data indicate that placental 
inflammation may be associated with poor pregnancy outcome (Weaver et al., 2005).  
Taking into consideration the importance of placental Tregs in pregnancy maintenance 
reported for both human and murine systems, we believe feline placental Tregs may be 
implicated in the cat system as well.  Therefore, our purpose was to identify Treg 
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populations (CD4+CD25+ T cells) in early and late gestation, formalin-fixed placental 
tissues from both FIV-infected and control queens using immunohistochemistry (IHC) 
and confocal microscopy.  Early gestation, formalin-fixed placental tissues were 
sectioned and subjected to IHC procedures using both monoclonal and polyclonal 
antibodies to detect T cell markers.  Despite variations in antibody treatments and 
blocking procedures, non-specific antibody binding was an unresolvable problem that 
precluded our ability to identify Tregs, specifically, in placental sections.    
 





Formalin-fixed placental tissues were sectioned to a thickness of 4 µm using a 
cryostat and placed on poly-L-lysine-coated, RNAse-free slides.  Sections were allowed 
to air dry for 1h or overnight.  After drying, the sections were washed twice, 5 min each, 
in wash buffer (Tris-HCl containing 0.5% Tween).  To reverse the protein cross-linking 
caused by formalin fixation, antigen retrieval was performed by placing each slide in 




After antigen retrieval, the sections were washed three times, 5 min each, and 
treated for 30 min with a variety of blocking solutions to identify one that would best 
minimize non-specific antibody binding.  These blocking solutions included serum-free 
block (2% BSA and 8% DMSO in 100 mL PBS containing 200 µl Triton X-100), blotto 
(5% non-fat dry milk in wash buffer), 5% bovine serum albumin (BSA), and 5% mouse, 
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horse, or rabbit serum, according to the primary antibody used.  We also used reduced L-
Glutathione, mouse Fc block, and purified cat IgG.  The primary antibodies used in these 
experiments targeted T cell markers CD4, CD8, CD25, and FOXP3 and are described in 
Table 1.  Primary antibodies were diluted to 1:10,000, added to the sections, and slides 
were incubated for 30 min at 37°C on a slide warmer.  Sections were then washed three 
times, 5 min each, in wash buffer.  If a labeled primary antibody was used, the slides 
were then incubated with a DNA stain, DAPI (4,6-diamidino-2-phenylindole), for 5 min, 
then washed three times, 5 min each.  If an unlabeled primary antibody was used, the 
sections were incubated with the secondary antibody (rabbit anti-goat IgG whole 
molecule conjugated with FITC), diluted 1:1,000, and placed on a slide warmer at 37°C 
for 30 min.  After three, 5 min washes to remove unbound secondary antibody, the slides 
were incubated with DAPI for 5 min, and washed again.  Slides were mounted with a 




Each section was observed using a confocal microscope (Zeiss LSM 510).  
Fluorescent detection was done at a wavelength of 521nm for FITC, 570nm for R-PE, 
and 461 for DAPI.  Differential inference contrast (DIC), a transmission mode, was used 
to enhance the contrast of the transparent sample and give a three dimensional picture of 
the sections.  
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Table A.1   Antibodies used in Immunohistochemistry 
Target Antibody Description Label Source 
CD4 Mouse anti-feline CD4 (clone 3-4F4) None Southern Biotech  
Mouse anti-feline CD4 (clone 3-4F4) R-PE Southern Biotech 
Goat anti-feline CD4 (polyclonal) 
(Product no. AF2597) 
None R&D Systems  
CD8 Mouse anti-feline CD8 (clone fCD8) None Southern Biotech  
Mouse anti-feline CD8 (clone fCD8) FITC Southern Biotech 
Goat anti-feline CD8 (polyclonal) 
(Product no. AF2598) 
None R&D Systems  
CD25 Mouse anti-feline CD25 FITC Dr. Gregg Dean*  
 
FOXP3 Mouse anti-mouse/rat FOXP3  
(Product no. 11-5773-80) 
FITC eBioscience   
Goat 
IgG 
Mouse anti-goat IgG    
(Product no. F7367) 
FITC Sigma Aldrich 
* North Carolina State University 
Note: R-PE = R-phycoerthrin 








Primary, monoclonal antibodies to CD4, CD8, CD25, and FOXP3 were used to 
quantify CD4+ and CD8 + T cell populations within the placental tissues and to identify 
Tregs (CD4+CD25+FOXP3+) within the T cell population (Figure A.1).  Unfortunately, 
we were unable to either quantify T cells or distinguish the Treg population within the 
sections because all antibodies bound non-specifically.  A number of variations in 
antibody treatment were performed to eliminate non-specific binding.  Those treatments 
included varying the dilution of the antibodies (10 fold dilutions starting at 1:100), 
diluting the antibody with blocking solutions, and varying the incubation time and 
temperature (30 min at 37°C or 1 h at room temperature).  Although our problem was not 
resolved, we found that diluting the monoclonal antibodies to 1:10,000 and incubating 




We treated the placental sections with a variety of blocking solutions to identify 
one that would best minimize non-specific antibody binding.  Sections were blocked for 
30 min, 1 h, and overnight with serum-free block, blotto, BSA, and mouse, horse, and 
rabbit serum.  We found that serum-free block best reduced the background noise seen in 
the confocal images.  It did not, however, eradicate the non-specific binding seen with the 
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Figure A.1   Immunohistochemistry of Early Gestation, Formalin-Fixed Placenta Tissues 
from Queen 6108 using Mouse, Monoclonal Antibodies to T cell Markers as 
the Primary Antibody 
 
Antibodies were conjugated as follows: anti-CD4-R-PE (red); anti-CD8-FITC (green); 
anti-CD25-FITC (green).  All sections were stained with the nuclear stain DAPI (blue).  
(a) Placenta C was coincubated with monoclonal antibody to CD4 and CD8.  Bottom 
right panel shows merged images.  (b) Placenta B was coincubated CD4 and CD25.  
Bottom right panel shows merged images.  (c) Placenta B was incubated with FOXP3.  





After unsuccessful IHC using monoclonal antibodies and various blocking 
solutions, we used primary, polyclonal antibodies to quantify CD4+ and CD8+ T cell 
populations within the formalin-fixed placental tissues.  Incubation with a primary and 
secondary antibody proved inconclusive (Figure A.2a).  In order to determine if non-
specific binding remained, we incubated placental sections with secondary antibody only 
(Figure A.2b).  Secondary antibody reacted with the tissues, showing non-specificity of 
antibody binding.  We then attempted the same variations in antibody treatment used with 
the monoclonal antibodies.  Good fluorescent labeling was produced with the secondary 
antibody diluted at 1:10,000 and incubated on the sections for 30 min at 37°C.  
 
Reduced L-Glutathione (GSH) 
 
Reduced L-Glutathione (GSH) is a thiol reactive compound that binds antibody 
sulfhydryl (SH) residues (Rogers et al., 2006).  We used this block in an attempt to 
prevent unwanted disulfide bridges between the thiol groups on antibodies and placental 
tissues which would cause a non-specific interaction.  Antibodies were pre-treated with 
diluted GSH at concentrations of 0, 3, 6, 9, or 30 mM, and incubated on ice for 1h before 
being added to the placental sections.  The same concentrations of GSH were used to 
block the sections.  Although GSH reduced some non-specific binding of the monoclonal 
antibodies (Figure A.3a), it did not reduce non-specific secondary antibody binding 










Figure A.2   Immunohistochemistry of Early Gestation, Formalin-Fixed Placenta Tissues 
from Queen 0373 using Goat, Polyclonal Antibody to CD4 as the Primary 
Antibody 
 
Secondary antibody was conjugated with FITC (green).  Sections were stained with 
DAPI (blue).  (a) Placenta C was incubated with anti-CD4 and secondary antibody and 
(b) placenta B was incubated with secondary antibody only (green).  Both sections were 
incubated with the DNA stain, DAPI.  Bottom right panels show merged images.  Top 








Figure A.3   Immunohistochemistry of Early Gestation, Formalin-Fixed Placenta Tissues 
from Queen 0373 using Reduced L-Glutathione 
 
Placental sections were blocked with various dilutions of reduced glutathione before 
incubating with primary antibody.  (a) Placenta C was coincubated with primary, 
monoclonal antibodies (anti-CD4-R-PE; red and anti-CD8-FITC; green) and blocked 
with 3mM of glutathione.  (b) Placenta B was incubated with secondary antibody only 
(green) and blocked with 6mM of glutathione.  Top right panel shows the image in 
transmission mode.  Both sections (a and b) were incubated with DAPI (blue).  Bottom 
right panels show merged images.  Magnification 1500X. 
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Mouse Fc Block 
 
Mouse Fc block was used in an attempt to block the Fc receptors, known to be 
present on placental tissues (Simister et al., 1996), to which the antibodies may bind non-
specifically.  Sections were incubated for 5 min at room temperature or 4°C with mouse 
Fc block at a concentration of 1µg/mL (Figure A.4).  This blocking protocol alleviated 
much of the background noise seen on the confocal images but it did not stop either the 
monoclonal antibody (anti-CD4) (Figure A.4a) or secondary antibody (Figure A.4b) from 
binding non-specifically.  
 
Purified Cat IgG 
 
Honig et al (2005) reported difficulty performing IHC in human placental tissues 
due to non-specific reactivity of monoclonal antibodies of IgG2b isotype to placental 
tissues.  Knowing that this problem was resolved by blocking specimens with human 
IgG, we attempted to reproduce this blocking procedure using purified feline IgG.  
Sections were incubated with the purified feline IgG for 30 min at room temperature 
followed by incubation with monoclonal antibodies for 30 min at 37°C.  This treatment 



















Figure A.4   Immunohistochemistry of Early Gestation, Formalin-Fixed Placenta Tissues 
from Queen 0373 using Mouse Fc Block  
 
Placental sections were blocked with mouse Fc block before incubation with primary 
antibody.  (a) Placenta F was incubated with primary, monoclonal antibody anti-CD4-R-
PE or (b) secondary antibody only.  Both sections were incubated with DAPI.  Bottom 
right panels show merged images.  Top right panels show the image in transmission 





Using the FIV-infected cat model, we demonstrated very high rates of MTCT and 
reproductive failure at both early and late pregnancy (Weaver et al., 2005; Boudreaux et 
al., 2009).  Moreover, our data indicate that placental inflammation may be associated 
with poor pregnancy outcome (Weaver et al., 2005).  With the knowledge that placental 
Tregs allow maternal tolerance of the semi-allogeneic fetus in both the mouse model and 
in humans (Zenclussen et al., 2005; Michaelsson et al., 2006), we believe feline placental 
Tregs may be implicated in the cat system as well.  Our aim was to identify, specifically, 
Treg populations (CD4+CD25+ T cells) in early and late gestation, formalin-fixed 
placental tissues from both FIV-infected and control queens using IHC and confocal 
microscopy.  
Early gestation, formalin-fixed placental tissues were sectioned and stained using 
both monoclonal and polyclonal antibodies.  Although all antibodies bound non-
specifically, we found good fluorescent labeling when the antibodies were diluted 
1:10,000 and sections were incubated for 30 min at 37°C.  Several blocking solutions 
were tested to identify one that would eliminate non-specific binding.  Unfortunately, we 
were unable to eliminate non-specific binding completely.  We did, however, find that 
serum-free block, reduced L-Glutathione (GSH), and mouse Fc block did the best at 
alleviating excess background noise seen on the confocal images.   
Interestingly, non-specific binding did not occur uniformly on all cells in the 
specimen.  It was readily apparent by comparing patterns of DAPI staining with patterns 
of antibody reactivity, that only subpopulations of placental cells were bound by the 
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antibodies.  However, when an antibody was reactive with cells, those same cells were 
bound by all other antibodies.  The reason for this finding is unknown at the present time. 
Other investigators reported difficulty in performing IHC in human placental 
tissues due to non-specific reactivity of monoclonal antibodies of IgG2b isotype to 
placental tissues (Honig et al., 2005).  The problem was resolved by blocking specimens 
with human IgG.  However, our attempt to reproduce this blocking procedure using 
purified feline IgG failed to eliminate the non-specific reactivity.    
The problems that we encountered with non-specific antibody binding in feline 
placental tissues were not adequately corrected, and thus, these studies were not pursued 
beyond those presented herein, due to lack of funds to support further experimentation.  
A priority of future research will be to quantify feline placental Tregs as we determine a 
role for these cells in FIV-induced placental immunopathology and reproductive 
compromise.  The value of the present study is that it provides essential knowledge with 
regard to usage of antibodies and blocking agents, antigen retrieval, and IHC and 







Anderson, V., Carneiro, M, Bulterys, M, Douglas, G, Polliotti B, Slikker W, Jr. (2001) 
HIV in pregnancy.  Perinatal infections: HIV and co-infections in the placenta and 
therapeutic interventions- a workshop report. Placenta 22 (Supplement A), 
Trophoblast Research 15, S34-S37. 
 
Boudreaux, C.E., Lockett, N.N., Chemerys, D.N., Clay, B.T., Scott, V.L., Willeford, B., 
Brown, T. and Coats, K.S. (2009) Maternal Hematological and Virological 
Characteristics during Early Feline Immunodeficiency Virus (FIV) Infection of 
Cats as Predictors of Fetal Infection and Reproductive Outcome at Early 
Gestation. Veterinary Immunology and Immunopathology In Press, Accepted 
Manuscript. 
 
Chao, K.H., Wu, M.Y., Yang, J.H., Chen, S.U., Yang, Y.S. and Ho, H.N. (2002) 
Expression of the interleukin-2 receptor alpha (CD25) is selectively decreased on 
decidual CD4+ and CD8+ T lymphocytes in normal pregnancies. Mol Hum 
Reprod 8, 667-73. 
 
D'Ubaldo, C., Pezzotti, P., Rezza, G., Branca, M. and Ippolito, G. (1998) Association 
between HIV-1 infection and miscarriage: a retrospective study. DIANAIDS 
Collaborative Study Group. Diagnosi Iniziale Anomalie Neoplastiche AIDS. Aids 
12, 1087-93. 
 
Goldstein, P., Smit, R, Stevens, M., Sever, JL. (2000) Association between HIV in 
pregnancy and antiretroviral therapy including protease inhibitors and low birth 
weight infants. Infectious diseases in obstetrics and gynecology 8, 94-98. 
 
Heikkinen, J., Mottonen, M., Alanen, A. and Lassila, O. (2004) Phenotypic 
characterization of regulatory T cells in the human decidua. Clin Exp Immunol 
136, 373-8. 
 
Honig, A., Rieger, L., Kapp, M., Dielt, J. and Kammerer, U. (2005) 
Immunohistochemistry in human placental tissue-pitfalls of antigen detection. 
Histo and Cytochem v53(11), 1413-1420. 
 
Kumar, R.M., Uduman, S.A. and Khurranna, A.K. (1995) Impact of maternal HIV-1 
infection on perinatal outcome. Int J Gynaecol Obstet 49, 137-43. 
 
Michaelsson, J., Mold, J.E., McCune, J.M. and Nixon, D.F. (2006) Regulation of T cell 
responses in the developing human fetus. J Immunol 176, 5741-8. 
 
Rogers, A.B., Cormier, K.S. and Fox, J.G. (2006) Thiol-reactive compounds prevent 
nonspecific antibody binding in immunohistochemistry. Lab Invest 86, 526-533.  
61 
 
Rollins, N.C., Coovadia, H.M., Bland, R.M., Coutsoudis, A., Bennish, M.L., Patel, D. 
and Newell, M.L. (2007) Pregnancy outcomes in HIV-infected and uninfected 
women in rural and urban South Africa. J Acquir Immune Defic Syndr 44, 321-8. 
 
Sasaki, Y., Sakai, M., Miyazaki, S., Higuma, S., Shiozaki, A. and Saito, S. (2004) 
Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy 
subjects and spontaneous abortion cases. Mol Hum Reprod 10, 347-53. 
 
Somerset, D.A., Zheng, Y., Kilby, M.D., Sansom, D.M. and Drayson, M.T. (2004) 
Normal human pregnancy is associated with an elevation in the immune 
suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112, 38-43. 
 
Weaver, C.C., Burgess, S.C., Nelson, P.D., Wilkinson, M., Ryan, P.L., Nail, C.A., Kelly-
Quagliana, K.A., May, M.L., Reeves, R.K., Boyle, C.R. and Coats, K.S. (2005) 
Placental immunopathology and pregnancy failure in the FIV-infected cat. 
Placenta 26, 138-47. 
 
Zenclussen, A.C., Gerlof, K., Zenclussen, M.L., Sollwedel, A., Bertoja, A.Z., Ritter, T., 
Kotsch, K., Leber, J. and Volk, H.D. (2005) Abnormal T-cell reactivity against 
paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced 
CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion 
model. Am J Pathol 166, 811-22. 
 
Zhu, X.Y., Zhou, Y.H., Wang, M.Y., Jin, L.P., Yuan, M.M. and Li, D.J. (2005) Blockade 
of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and 
expands peripheral CD4+CD25+ regulatory T cells to rescue abortion-prone 
fetuses. Biol Reprod 72, 338-45. 
